A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
about
Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide.Phage display of random peptide libraries: applications, limits, and potential.A phage display screen and binding studies with acetylated low density lipoprotein provide evidence for the importance of the scavenger receptor cysteine-rich (SRCR) domain in the ligand-binding function of MARCO.Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockadePhage display in molecular imaging and diagnosis of cancer.Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity.In vitro selection of a peptide inhibitor of human IL-6 using mRNA display.Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Antibody phage display libraries: contributions to oncology.Molecular mechanism of a novel CD59-binding peptide sp22 induced tumor cells apoptosis.Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.Design of growth factor sequestering biomaterialsEngineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways.Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.Advancement and applications of peptide phage display technology in biomedical scienceIn vitro selection technologies to enhance biomaterial functionality.A peptoid antagonist of VEGF receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site.A prostate-specific antigen-dependent fusion polypeptide inhibits growth of prostate cancer cells in vitro and in vivo.Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.Antibody Engineering for Pursuing a Healthier FutureShort peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.Histological and immunohistochemical studies on the epididymal duct in the dromedary camel (Camelus dromedarius).Specific VEGF sequestering to biomaterials: influence of serum stability.Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models.AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro.Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
P2860
Q31007381-8160B9A0-6973-4BC5-B686-74F5A6C077E0Q31039269-0742572D-AAA5-4C3A-AA0F-F2554B8DC3D1Q33235835-D815DB41-2E05-4E66-9F29-EDD04367BBECQ33256392-17F84ACB-BD93-47C4-8970-CAF654984E9FQ33327051-658A0A42-4B13-4977-973A-7D4672A497F3Q33532734-8C4FE82F-5459-4B91-BCCC-20214D56CF74Q33592506-D9A624CD-18BC-4639-AF7E-7A8BACEBD0C9Q33764315-59FB8A26-8871-4FE1-8674-0B85D2E0E909Q34273411-FF80A870-1D71-46C5-9D54-3CA1AB74A1F9Q34323991-38C7B559-AFE2-4E15-9AD0-9BB1C7B33DBAQ34347455-F6046DCC-F8F6-46C3-B0C8-72B16EDD1C73Q34385892-69803C47-7F11-40F4-9210-5ED1DC43A1CCQ34543371-6F20F277-EEFB-4F70-97BF-2EEB3D118FD0Q34787415-F7C0F69C-02CC-40FF-AEE2-C2D6C0A91F23Q35166954-DBFA34A7-3728-4A4A-9D56-A27505219BE0Q35898339-6A16971D-6E56-4617-8DA3-722195C7EDDCQ36020230-F1358379-224A-4AF4-8B07-B28F7E443773Q36762954-73D52244-E988-48C3-BBB6-14A4FF0C23BDQ36958387-B1BEBF61-611C-429C-9027-CD9FCA803400Q38067265-30C483F1-11BD-4F8B-9F98-DB2CB65ABB66Q38731632-01073BF8-21D5-4AD1-9AD7-02F5123CDC19Q38767147-0821A48C-887F-4022-9EEF-1E97DCA09220Q40284293-89EBBDC4-1F1F-417B-94F8-B49A32561984Q42049840-97B07E23-FFBD-4FB9-8A0E-7AD7BDEE6F6DQ43650798-780DC7B7-551F-4511-B549-A8AF2F6FBD7FQ47117976-9A94F8CD-0CE9-421E-A744-B8BD1A857838Q55472739-BDC49C35-3271-4643-9B92-C2235BF8E2F1
P2860
A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A novel peptide isolated from ...... to its kinase domain receptor.
@ast
A novel peptide isolated from ...... to its kinase domain receptor.
@en
type
label
A novel peptide isolated from ...... to its kinase domain receptor.
@ast
A novel peptide isolated from ...... to its kinase domain receptor.
@en
prefLabel
A novel peptide isolated from ...... to its kinase domain receptor.
@ast
A novel peptide isolated from ...... to its kinase domain receptor.
@en
P2093
P2860
P356
P1476
A novel peptide isolated from ...... to its kinase domain receptor.
@en
P2093
Lei Hetian
Liu Meisheng
Liu Xiaoying
Shou Chengchao
Song Shumei
Yang Junshan
P2860
P304
43137-43142
P356
10.1074/JBC.M203103200
P407
P577
2002-08-14T00:00:00Z